Clinical Trial

Early Feasibility of 'Pivot Extend' for Tricuspid Regurgitation Treatment

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 11, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
This clinical trial aims to evaluate the safety and demonstrate the efficacy of treatment to improve tricuspid regurgitation (TR) symptoms in patients with severe and clinically symptomatic TR through long-term implantation of an investigational medical device. 1. Determine the safety of long-term implantation of the investigational medical device "Pivot Extend" by monitoring for MACEs associated with the investigational medical device or procedure that may occur with long-term associated with the investigational medical device or procedure that may occur with long-term implantation. 2. Device success, procedural success, and clinical outcomes of long-term implantation of the investigational medical device "Pivot Extend" will be monitored.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-10.
Trial Details
NCT Number NCT06877520
Lead Sponsor Tau-MEDICAL Co., Ltd.
Conditions Tricuspid Regurgitation (TR)
Enrollment 7 participants
Start Date 2025-05
Primary Completion 2026-05 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-11